The Evolving Role of Targeted Biological Agents in the Management of Indolent B-Cell Lymphomas
Therapeutic Advances in Hematology - United States
doi 10.1177/2040620717738740
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 22, 2017
Authors
Publisher
SAGE Publications